Market Place
Sourcing Support
Amgen Wins Ruling on Patents for Kyprolis Cancer Drug
05 May 2020 //
BLOOMBERG
After exiting troubled Merrimack, former CEO becomes new chief at Yumanity
10 Jul 2019 //
FIERCE BIOTECH
Natco, Onyx settle cancer drug patent litigation
01 Jun 2019 //
ECONOMIC TIMES
Natco settles patent dispute with Onyx for blood cancer drug Carfilzomib
31 May 2019 //
MONEYCONTROL
Natco, Onyx settle cancer drug patent litigation
30 May 2019 //
ECONOMIC TIMES
Cerdelga (eliglustat) : Genzyme vs. Cipla Ltd.
24 Nov 2018 //
PATENT LITIGATION
Cerdelga (eliglustat): Genzyme vs. Dr. Reddy’s Labs
24 Nov 2018 //
PATENT LITIGATION
Nexavar (sorafenib tosylate) : Bayer HealthCare vs. Apotex Inc.
19 Oct 2018 //
PATENT LITIGATION
Kyprolis® (Carfilzomib) : Onyx Therapeutics v. Cipla Limited
20 Apr 2018 //
PATENT LITIGATION
Peloton`s Appoints Helen S. Kim, M.B.A. & David Chang, M.D., Ph.D. to BOD
22 Mar 2018 //
PRESS RELEASE
Kyprolis® (Carfilzomib):Onyx Therapeutics, Inc. v. Breckenridge Pharmaceutical
16 Feb 2018 //
PATENT LITIGATION
Ipca Expands to U.S. Market
30 Jan 2018 //
CONTRACT PHARMA
Kyprolis® (Carfilzomib) : Onyx Therapeutics V. Apotex
24 Jan 2018 //
PATENT LITIGATION
Kezar adds $50M to its funding tally for immunoproteasome drug
26 Jul 2017 //
FIERCE BIOTECH
Kyprolis® (carfilzomib): Onyx Therapeutics, Inc. V.Teva Pharmaceuticals USA
20 Apr 2017 //
PATENT LITIGATION
Amgen teams with NPR-famed StoryCorps to collect and share myeloma stories
07 Dec 2016 //
FIERCE PHARMA
J&J`s Darzalex leaps ahead in multiple myeloma lineup with new FDA approval
22 Nov 2016 //
FIERCE PHARMA
Genmab to Trial Darazalex in Combination with Carfilzomib to Treat Myeloma
18 Nov 2016 //
EUROPEAN PHARMACEUTICAL
Bayer seeks expanded marketing nod from US, Japan & EU
08 Nov 2016 //
PHARMABIZ
A Look at Amgen and Its $10 Billion Flop Onyx
02 Nov 2016 //
BIOSPACE
Amgen balks over meeting to review cost of bone cancer drugs
07 Apr 2016 //
STAT
Big Pharma finds second chance for failed drugs in China
30 Mar 2016 //
FIERCE PHARMA ASIA
Chinese Market Offers New Life to Many Drugs
29 Mar 2016 //
FIRST WORD PHARMA
With $70M in VC cash, Tizona takes a fresh approach to immuno-oncology
09 Mar 2016 //
FIERCE BIOTECH
Google`s Verily to Lease Onyx`s Old Space in South San Francisco
18 Feb 2016 //
BIOSPACE
Biogen, Sanofi back Tony Coles` neurodegeneration player Yumanity
10 Feb 2016 //
FIERCE BIOTECH
Fidelity, Biogen, Sanofi Join $45M Bet on Alzheimer`s and Parkinson`s Startup
10 Feb 2016 //
FORBES
Surging demand for APIs prompts expansion of second Onyx facility
01 Feb 2016 //
IN PHARMATECHNOLOGIST
FDA approves new Kyprolis combination therapy for the treatment
22 Jan 2016 //
PR NEWSWIRE
Key Points Amgen CEO Bob Bradway Made at J.P. Morgan
14 Jan 2016 //
BIOSPACE
Cancer Drug Quest Drives Bayer`s Pipeline Investment
12 Dec 2015 //
BLOOMBERG
Amgen M&A Speculation Heats Up With Four Potential Targets
10 Nov 2015 //
BIOSPACE
Amgen (AMGN) on the Prowl for Potential $10 Billion Deal
09 Nov 2015 //
BIOSPACE
Amgen Opens Up $300 Million Facility in Ireland
25 Aug 2015 //
BIOSPACE
Amgen (AMGN) Beats Sanofi (SAN.PA) to Market with EU Hurdle for Anti-Cholesterol Drug
23 May 2015 //
BIOSPACE
Amgen (AMGN), Sanofi (SAN.PA) in Race to Get European Green light for Anti-Cholesterol Drugs
21 May 2015 //
BIOSPACE
Australia`s Sirtex eyed by Bayer for radioactive attraction?
18 May 2015 //
FIERCE PHARMA ASIA
Struggling Glaxosmithkline Warns Of 150 R&D Job Cuts In Philadelphia
18 Mar 2015 //
FIERCE BIOTECH
Amgen to Cut About 300 Jobs, Close One Buildings in South San Francisco
10 Mar 2015 //
PHARMALOT
Genmab Data Points To Early Bone Cancer Drug Launch: Analysts
04 Feb 2015 //
REUTERS
